Targeting Glycolysis in Leukemia: A novel inhibitor 3-BrOP in combination with Rapamycin

Por Akers, Lauren J., Fang, Wendy, Levy, Alejandro G., Franklin, Anna R., Huang, Peng, Zweidler-McKay, Patrick A.
Publicado no Leuk Res (2011)

The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

Por Levy, Alejandro G., Zage, Peter E., Akers, Lauren J., Ghisoli, Maurizio L., Chen, Zhao, Fang, Wendy, Kannan, Sankaranarayanan, Graham, Timothy, Zeng, Lizhi, Franklin, Anna R., Huang, Peng, Zweidler-McKay, Patrick A.
Publicado no Invest New Drugs (2010)

Notch activation inhibits AML growth and survival: a potential therapeutic approach

Por Kannan, Sankaranarayanan, Sutphin, Robert M., Hall, Mandy G., Golfman, Leonard S., Fang, Wendy, Nolo, Riitta M., Akers, Lauren J., Hammitt, Richard A., McMurray, John S., Kornblau, Steven M., Melnick, Ari M., Figueroa, Maria E., Zweidler-McKay, Patrick A.
Publicado em 2013